Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Michael F Moran
Affiliation
Hospital for Sick Children, University of Toronto
ORCID
Career Start Year
1985
Papers
125
H Index
44
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36214668
Mitochondrial Aconitase ACO2 Links Iron Homeostasis with Tumorigenicity in Non-Small Cell Lung Cancer.
Mol Cancer Res
2023
37855416
Activation of mitogen-activated protein kinase signaling and development of papillary thyroid carcinoma in thyroid-stimulating hormone receptor D633H knockin mice.
Eur Thyroid J
2023
38052158
Activation of mitogen-activated protein kinase signaling and development of papillary thyroid carcinoma in thyroid-stimulating hormone receptor D633H knockin mice.
Eur Thyroid J
2023
37028761
The ubiquitin ligase HERC4 suppresses MafA transcriptional activity triggered by GSK3β in myeloma by atypical K63-linked polyubiquitination.
J Biol Chem
2023
36070144
Oncohistone interactome profiling uncovers contrasting oncogenic mechanisms and identifies potential therapeutic targets in high grade glioma.
Acta Neuropathol
2022
35383171
Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies distinct proteotypes associated with patient outcomes.
Nat Commun
2022
35739422
Author Correction: Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome.
Nat Cancer
2022
35613471
Engineered SH2 Domains for Targeted Phosphoproteomics.
ACS Chem Biol
2022
35422502
Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome.
Nat Cancer
2022
35362478
Tankyrase represses autoinflammation through the attenuation of TLR2 signaling.
J Clin Invest
2022
35595168
Proteomic Characterization of a Candidate Polygenic Driver of Metabolism in Non-small Cell Lung Cancer.
J Mol Biol
2022
32842143
Targeting the Otub1/c-Maf axis for the treatment of multiple myeloma.
Blood
2021
33617900
SLAP2 Adaptor Binding Disrupts c-CBL Autoinhibition to Activate Ubiquitin Ligase Function.
J Mol Biol
2021
34680183
Reinspection of a Clinical Proteomics Tumor Analysis Consortium (CPTAC) Dataset with Cloud Computing Reveals Abundant Post-Translational Modifications and Protein Sequence Variants.
Cancers (Basel)
2021
32539411
Data Dependent-Independent Acquisition (DDIA) Proteomics.
J Proteome Res
2020
32094923
A drug discovery platform to identify compounds that inhibit EGFR triple mutants.
Nat Chem Biol
2020
32009416
Repeat-Preserving Decoy Database for False Discovery Rate Estimation in Peptide Identification.
J Proteome Res
2020
31822558
The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival.
J Biol Chem
2020
32903271
Cancer proteome and metabolite changes linked to SHMT2.
PLoS One
2020
30431205
Engineered SH2 domains with tailored specificities and enhanced affinities for phosphoproteome analysis.
Protein Sci
2019
31330989
Somatic Alteration Burden Involving Non-Cancer Genes Predicts Prognosis in Early-Stage Non-Small Cell Lung Cancer.
Cancers (Basel)
2019
31292163
ID1 Is Critical for Tumorigenesis and Regulates Chemoresistance in Glioblastoma.
Cancer Res
2019
31249099
Prediction of LC-MS/MS Properties of Peptides from Sequence by Deep Learning.
Mol Cell Proteomics
2019
30713027
Structural and Functional Characterization of Ubiquitin Variant Inhibitors of USP15.
Structure
2019
30938160
Evosep One Enables Robust Deep Proteome Coverage Using Tandem Mass Tags while Significantly Reducing Instrument Time.
J Proteome Res
2019
30417091
A tyrosine sulfation-dependent HLA-I modification identifies memory B cells and plasma cells.
Sci Adv
2018
30158528
A feed forward loop enforces YAP/TAZ signaling during tumorigenesis.
Nat Commun
2018
30212448
Refined RIP-seq protocol for epitranscriptome analysis with low input materials.
PLoS Biol
2018
30297534
Pathologic Oxidation of PTPN12 Underlies ABL1 Phosphorylation in Hereditary Leiomyomatosis and Renal Cell Carcinoma.
Cancer Res
2018
27593927
Cellular stress induces TRB3/USP9x-dependent Notch activation in cancer.
Oncogene
2017
28285997
CCM-3 Promotes C. elegans Germline Development by Regulating Vesicle Trafficking Cytokinesis and Polarity.
Curr Biol
2017
28176486
Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome, and tyrosine-phosphatome in acute myeloid leukemia.
Proteomics
2017
28933784
Inhibition of the deubiquitinase USP5 leads to c-Maf protein degradation and myeloma cell apoptosis.
Cell Death Dis
2017
28673317
The ubiquitin-conjugating enzyme UBE2O modulates c-Maf stability and induces myeloma cell apoptosis.
J Hematol Oncol
2017
28877995
A neuroprotective agent that inactivates prodegenerative TrkA and preserves mitochondria.
J Cell Biol
2017
28894103
The Candida albicans transcription factor Cas5 couples stress responses, drug resistance and cell cycle regulation.
Nat Commun
2017
27880036
Protein-phosphotyrosine proteome profiling by superbinder-SH2 domain affinity purification mass spectrometry, sSH2-AP-MS.
Proteomics
2017
27750381
Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.
Int J Cancer
2017
26825710
The ubiquitin ligase HERC4 mediates c-Maf ubiquitination and delays the growth of multiple myeloma xenografts in nude mice.
Blood
2016
27797343
Reciprocal stabilization of ABL and TAZ regulates osteoblastogenesis through transcription factor RUNX2.
J Clin Invest
2016
27152361
Identification of human plasma cells with a lamprey monoclonal antibody.
JCI Insight
2016
25403733
Comprehensive identification of phosphorylation sites on the Numb endocytic adaptor protein.
Proteomics
2015
26237434
Distinct Regulation of Transmitter Release at the Drosophila NMJ by Different Isoforms of nemy.
PLoS One
2015
25721092
Comprehensive proteome analysis of fresh frozen and optimal cutting temperature (OCT) embedded primary non-small cell lung carcinoma by LC-MS/MS.
Methods
2015
25784717
CHCHD2 Is Coamplified with EGFR in NSCLC and Regulates Mitochondrial Function and Cell Migration.
Mol Cancer Res
2015
25588725
Signal transduction.
Proteomics
2015
25587033
Tyrosine phosphorylation of the Lyn Src homology 2 (SH2) domain modulates its binding affinity and specificity.
Mol Cell Proteomics
2015
25311528
Differential regulation of FGFR3 by PTPN1 and PTPN2.
Proteomics
2015
25330774
The major cystic fibrosis causing mutation exhibits defective propensity for phosphorylation.
Proteomics
2015
24453208
Proteomic profiles of human lung adeno and squamous cell carcinoma using super-SILAC and label-free quantification approaches.
Proteomics
2014
1 - 50 of 125
Column Actions
Search
Recommended Authors
Alexandre Rosa Campos
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
2015
Number of shared co-authors
0
Florent Dingli
Institut Curie, PSL Research University
Career Start Year
2011
Number of shared co-authors
1
Severa Bunda
Princess Margaret Cancer Centre
Career Start Year
2005
Number of shared co-authors
4
Erin D Jeffery
Agenus Inc, American Society for Mass Spectrometry, Hartwick College, Human Proteome Organisation, Large Scale Biology Corp, University of Virginia
Career Start Year
2005
Number of shared co-authors
2
Genevi??ve Lavoie
Institute for Research in Immunology and Cancer (IRIC)
Career Start Year
2004
Number of shared co-authors
1
Feng Yang
Howard Hughes Medical Institute, University of California San Diego
Career Start Year
2003
Number of shared co-authors
5
Barak Rotblat
Ben-Gurion University of the Negev
Career Start Year
2002
Number of shared co-authors
1
Jayantha Gunaratne
Institute of Molecular and Cell Biology
Career Start Year
2000
Number of shared co-authors
1
Rachel Toth
University of Dundee
Career Start Year
1999
Number of shared co-authors
1
Damarys Loew
Institut Curie, PSL Research University
Career Start Year
1996
Number of shared co-authors
1
Forest M White
Massachusetts Institute of Technology
Career Start Year
1995
Number of shared co-authors
9
Michael A White
University of Georgia
Career Start Year
1994
Number of shared co-authors
0
Manfred Koegl
Boehringer Ingelheim RCV GmbH & Co. KG
Career Start Year
1993
Number of shared co-authors
2
Ailan Guo
College of Animal Medicine, Xinjiang Agricultural University
Career Start Year
1992
Number of shared co-authors
3
Stephan M Feller
Institute of Molecular Medicine, Martin-Luther-University of Halle-Wittenberg
Career Start Year
1989
Number of shared co-authors
1
Kun-Liang Guan
University of California San Diego
Career Start Year
1988
Number of shared co-authors
2
Rakesh Kumar
Rutgers New Jersey Medical School
Career Start Year
1987
Number of shared co-authors
2
John Rush
Cell Signaling Technology Inc.
Career Start Year
1987
Number of shared co-authors
2
Hediye Erdjument-Bromage
Neuroscience Institute, NYU Grossman School of Medicine
Career Start Year
1984
Number of shared co-authors
4
Andrew D Cherniack
Dana-Farber Cancer Institute
Career Start Year
1984
Number of shared co-authors
9
Jorge Silvio Gutkind
Moores Cancer Center, University of California San Diego
Career Start Year
1984
Number of shared co-authors
4
Sylvain Meloche
Institute for Research in Immunology and Cancer
Career Start Year
1982
Number of shared co-authors
6
Ze'ev Ronai
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
1981
Number of shared co-authors
2
J. Wade Harper
Harvard Medical School
Career Start Year
1981
Number of shared co-authors
6
Ryuji Kobayashi
Tokyo University of Science
Career Start Year
1979
Number of shared co-authors
3
Sara A Courtneidge
Oregon Health & Science University
Career Start Year
1977
Number of shared co-authors
3
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year
1976
Number of shared co-authors
17
Karin D Rodland
Oregon Health and Science University
Career Start Year
1973
Number of shared co-authors
5
Jonathan M Backer
Albert Einstein College of Medicine
Career Start Year
1970
Number of shared co-authors
0
Tony Hunter
Salk Institute for Biological Studies
Career Start Year
1968
Number of shared co-authors
2
row(s) 1 - 30 of 30
Collaborators
Jiefei Tong
Hospital for Sick Children
Co-authored papers
42
Paul Taylor
Hospital for Sick Children
Co-authored papers
40
Ming-Sound Tsao
University Health Network, University of Toronto
Co-authored papers
17
Tony Pawson
Co-authored papers
12
Nhu-An Pham
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
10
Thomas Kislinger
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers
9
Frances A Shepherd
University Health Network, Princess Margaret Cancer Centre
Co-authored papers
7
Geoffrey Liu
The Princess Margaret Cancer Centre/University of Toronto
Co-authored papers
7
Vladimir Ignatchenko
Margaret Cancer Center
Co-authored papers
6
Suzanne Trudel
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
6
Brian Raught
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
5
Shingo Sakashita
National Cancer Center Exploratory Oncology Research & Clinical Trial Center
Co-authored papers
5
Ming Li
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
5
Yuhong Wei
Rosalind and Morris Goodman Cancer Institute, McGill University
Co-authored papers
5
Sachdev S Sidhu
School of Pharmacy, University of Waterloo
Co-authored papers
5
Jason Moffat
University of Toronto
Co-authored papers
5
Lei Li
Hospital for Sick Children
Co-authored papers
4
Wen Zhang
Nanjing Agricultural University
Co-authored papers
4
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
4
Cynthia Hawkins
The Hospital for Sick Children
Co-authored papers
3
Daniela Rotin
The Hospital for Sick Children
Co-authored papers
3
Mike Tyers
Institute for Research in Immunology and Cancer (IRIC), Universite de Montreal
Co-authored papers
3
Naoki Yanagawa
Yamagata Prefectural Central Hospital
Co-authored papers
3
Frank McCormick
Frederick National Laboratory for Cancer Research
Co-authored papers
3
Ivan Sadowski
University of British Columbia
Co-authored papers
3
Sameer Agnihotri
Co-authored papers
3
Dennis Wang
Sheffield Institute of Translational Neuroscience, University of Sheffield
Co-authored papers
3
Chang-Qi Zhu
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
3
Vibha Raghavan
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
3
Jeffrey L Wrana
Lunenfeld-Tanenbaum Research Institute Mount Sinai Hospital
Co-authored papers
3
1 - 30